## NUE: Nucor Corporation - XLB: Basic Materials

### Executive Summary

VALUE thesis: PEG 0.75 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: overbought RSI (72).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($152.12)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. GM Advisory Group LLC Invests $355,000 in Nucor Corporation $NUE**
- Source: MarketBeat | 20251129T120016 | Bullish | Relevance: 99%
- GM Advisory Group LLC has invested $355,000 in Nucor Corporation, acquiring 2,739 shares in Q2. Nucor has outperformed quarterly estimates, with EPS of $2.63 and revenue of $8.52 billion, and currently holds a "Moderate Buy" consensus target price of $167.20. Institutional investors own 76.48% of the stock, while insiders have recently sold shares totaling approximately $2.72 million.

**2. Nucor increases quarterly dividend to $0.56 per share By Investing.com**
- Source: Investing.com South Africa | 20251201T230200 | Bullish | Relevance: 99%
- Nucor Corporation announced a raise in its quarterly cash dividend to $0.56 per share, continuing a 53-year streak of annual increases. The steel manufacturer's shares have surged 47% in the past six months, despite an InvestingPro analysis indicating it's slightly overvalued. The company also reported strong Q3 2025 financial results, surpassing earnings expectations.

**3. Advisors Asset Management Inc. Sells 2,669 Shares of Nucor Corporation $NUE**
- Source: MarketBeat | 20251129T081345 | Somewhat-Bullish | Relevance: 99%
- Advisors Asset Management Inc. reduced its stake in Nucor Corporation (NYSE:NUE) by 11.9% during the second quarter, selling 2,669 shares and holding 19,720 shares valued at $2,555,000. Several other institutional investors also adjusted their positions in Nucor. The article details Nucor's stock performance, financial results, dividend announcement, analyst ratings, and recent insider selling activities.

**4. Wealthquest Corp Purchases Shares of 2,586 Nucor Corporation $NUE**
- Source: MarketBeat | 20251130T134122 | Bullish | Relevance: 98%
- Wealthquest Corp recently acquired a new stake of 2,586 Nucor Corporation (NYSE:NUE) shares, valued at approximately $335,000, during the second quarter. This accumulation of shares occurred despite insider selling activity totaling $2.72 million over the past three months. Nucor has also reported strong quarterly earnings, beating analyst estimates, and has received a "Moderate Buy" consensus rating from analysts with an average target price of $167.20.

**5. Nucor increases quarterly dividend to $0.56 per share**
- Source: Investing.com | 20251201T160100 | Bullish | Relevance: 98%
- Nucor Corporation announced an increase in its regular quarterly cash dividend to $0.56 per share, maintaining its 53-year streak of consecutive annual dividend increases. The dividend is payable on February 11, 2026, to stockholders of record as of December 31, 2025. Despite being slightly overvalued, Nucor's financial health is rated "GOOD" by InvestingPro, and the company recently reported strong Q3 2025 financial results, leading BMO Capital to raise its price target.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Jefferies | $190 | $170 | +12% |
| 2025-12-05 | JP Morgan | $200 | $175 | +14% |
| 2025-11-14 | Wells Fargo | $167 | $147 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Jefferies | main | Buy |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-11-14 | Wells Fargo | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($2.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 7 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-3.1%)
- State Farm Mutual Au: 10.6% (-0.7%)
- Blackrock Inc.: 8.1% (-3.6%)
- State Street Corpora: 5.3% (-2.7%)
- Berkshire Hathaway, : 2.8% (-3.1%)

### Key Risks

1. High beta (1.86) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Volume divergence: price rising (+1.4% MRS) on declining volume (64% of avg) suggests distribution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +13%) could attract flows.
- Momentum building: MRS_20 improving +1.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.75 indicates undervaluation relative to growth. Forward P/E 13.9x attractive for 42% earnings growth. Balance sheet: strong liquidity (2.8x). Analyst sentiment positive (3 raises, avg +13%). Insider selling cluster ($2.1M in 90 days), potential headwind. Institutional flow bullish (2 buying vs 7 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $37.6B |
| Beta | 1.86 |
| 52W Range | $97.59 - $166.27 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.75 |
| Forward P/E | 13.9 |
| Current P/E | 19.8 |
| YoY Growth | 42.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 5.0% to 6.3% (+1.4% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 94th percentile. MRS_5 at 1.3% confirms short-term momentum alignment. AM_20 at 7.5% shows strong absolute momentum above own 20MA. Outperforming sector by 4.4pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.17), confirming momentum. RSI overbought at 72, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.35% (CS: 95) | Strong |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 1.17 | Bullish |
| vs SMA20 | 1.075x | Above |
| vs SMA50 | 1.123x | Above |
| vs SMA200 | 1.209x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $160.70
- **Stop Loss:** $152.12 (5.3% risk)
- **Target:** $177.86 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 139
- **Position Value:** $22,337.30
- **Portfolio %:** 22.34%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-01-26 (Est: $2.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.16 | $2.63 | +22.0% |
| 2025Q2 | $2.61 | $2.60 | -0.6% |
| 2025Q1 | $0.61 | $0.67 | +9.8% |
| 2024Q4 | $0.64 | $1.22 | +90.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*